RISE Robotics Awarded U.S. Army Phase I Contract to Explore Advanced Collapsible Lightweight Crane Technology
SOMERVILLE, Mass.--(BUSINESS WIRE)--RISE Robotics, a leader in next-generation actuation technologies, today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) contract from the U.S. Army to explore the feasibility of developing collapsible, ultra-lightweight cranes for rapid deployment in resource-constrained and expeditionary environments.
The eight-month, $250,000 contract is sponsored by Letterkenny Army Depot and was awarded under the Army's Mobile Sustainment Tools Open Topic (A244-P056). The effort aims to evaluate how RISE's proprietary Beltdraulic™ actuation system can be leveraged to develop portable structural systems that are easy to transport, quick to assemble, and capable of withstanding harsh conditions.
'This effort reflects the Army's growing focus on enabling rapid mobility and logistical efficiency in the field,' said Tom Phelps, COO of RISE Robotics. 'With this Phase I award, we're excited to explore how our Beltdraulic technology can address critical operational gaps through lighter, more agile lifting equipment.'
The Phase I work builds on RISE's proven track record of delivering defense-grade lifting systems. RISE previously completed a Phase III production contract with the U.S. Air Force for the Common Lifting Device (CLD), a compact, electronic-free lift system developed to support the MC-130J Silent Knight Radar program. The CLD features a lift capacity of 200 pounds, a maximum lift height of 11 feet 10 inches, and a total system weight of just 215 pounds, all within a 6'X3'X3" footprint. Its successful transition to production highlights RISE's ability to deliver innovative, field-deployable solutions at scale.
Under this new Army contract, RISE will investigate how its CLD platform and Beltdraulic architecture can be adapted to meet Army-specific needs. This includes exploring structural modifications, such as moving boom-type crane arms, evaluating the use of larger wheels for off-road mobility, and developing design variants for lower-profile lifting use cases. RISE team members will engage directly with Army personnel to gather operational insights and define mission-driven requirements for future development.
The Phase I effort will include demonstrating CLD capabilities to Army stakeholders, developing a tailored requirements document based on end-user feedback, and a roadmap identifying high-impact Army applications for a next-generation collapsible crane. The outcome will help shape a potential Phase II program to deliver a prototype that meets expeditionary mission requirements.
For more information about RISE Robotics and its advanced lifting technologies, visit www.riserobotics.com.
About RISE Robotics:
RISE Robotics is transforming industrial actuation with Beltdraulic™, a fluid-free linear actuator technology that delivers hydraulic-like power without the disadvantages. Using a belt-and-pulley system instead of oil, Beltdraulic enhances mission readiness by cutting fuel consumption (and associated logistical costs) in half, eliminating exposure of personnel to pollutants, and significantly reducing maintenance and manpower requirements.
RISE is a Reg CF company, allowing both accredited and non-accredited investors to own a piece of its innovative technology through Wefunder.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
/C O R R E C T I O N -- Meala/
In the news release, Meala Partners with dsm-firmenich to Commercialize Texturizing Protein for Meat Alternatives, issued June 3, 2025 by Meala over PR Newswire, we are advised by the company that edits have been made to the release. The complete, corrected release follows: PB Pea protein, a high-performance texturizer is ready for market release in Europe, bringing cleaner labels and better nutritional value to meat alternatives HAIFA, Israel, June 3, 2025 /PRNewswire/ -- Plant-based innovator Meala FoodTech Ltd. partners with dsm-firmenich to launch Vertis™ PB Pea — a groundbreaking texturizing pea protein. This single, multifunctional ingredient is designed to replace modified binders like hydrocolloids, helping to clean up labels in plant-based meat alternatives. The product is now available in Europe via dsm-firmenich as Vertis™ PB Pea. PB Pea, is a clean-label texturizer produced using biotechnology. Protected by two patents, it consolidates the functionality of multiple components into a single, versatile ingredient that delivers unmatched binding, gelation, and emulsifying properties. Furthermore, it increases the protein content of the final product. This holistic solution can replace an entire binding system often found in meat alternatives, while keeping the label short and recognizable. PB Pea was tested to great success in various meat alternative applications and suits any formulation, such as burgers, sausages and nuggets and more. Key benefits of PB Pea: Clean label and allergen-free: Clearly labeled as "pea protein." Thermostability: Maintains performance under heat and low temperature for versatile applications. Excellent texture and water retention: Provides juiciness and structure in meat alternatives. Enhanced nutritional value: Increases protein content. Short ingredient list: Enables producers to shorten and clean up the ingredient list. There is a clear shift in consumer behavior globally. Customers are increasingly drawn to products that deliver both an enjoyable taste experience and a clean, simple ingredient list that supports their well-being goals. To meet these rising expectations and drive meaningful growth, food manufacturers are seeking all-in-one ingredient solutions. "This is exactly where our product comes in," says Tali Feldman Sivan, CBO and co-founder of Meala FoodTech. "It addresses both functionality and clean-label demands, while replicating the sensory profile and experience of conventional meat products." With health and transparency rising in importance, European consumers are fueling a clean-label shift in the food industry. According to recent research1 from the EIT Food Consumer Observatory—a pan-European study on consumer perceptions of ultra-processed foods -- two-thirds of Europeans (67%) say they dislike unknown ingredients in their food, while just over half (56%) actively try to avoid processed foods. This growing awareness is reshaping preferences -- especially in the plant-based sector. In response, food manufacturers are under pressure to reformulate products and embrace cleaner, simpler labels to meet the rising demand for healthier, more natural options that don't compromise on taste or convenience With the launch of Vertis™ PB Pea, dsm-firmenich is expanding its Vertis™ plant protein portfolio -- introducing an innovative ingredient that consolidates the functionality of multiple components in plant-based meat alternatives. "We are grateful to our partners at dsm-firmenich, who offer decades of experience as industry leaders in bringing innovative products to market," exclaims Hadar Ekhoiz Razmovich, CEO and co-founder of Meala FoodTech. "Their application support, regulatory expertise, and ability to drive global commercial rollouts are unprecedented. We're impressed by their innovation-driven approach and deep understanding of the food industry. dsm-firmenich believed in us from the very beginning -- not only as investors, but as true partners -- offering guidance, trust, and strategic support that helped lay the foundation for this powerful collaboration." Meala's partnership with dsm-firmenich -- a global leader in food ingredients -- combines both distribution and venture investment. The agreement paves the way for Meala's innovative pea-based texturizer to enter new global markets and fuel the next wave of plant-based product innovation. With production already underway in Europe, Meala's functional pea protein is scaling to meet growing international demand. "We're looking forward to working with dsm-firmenich to lead the new era of plant-based alternatives that successfully merge high performance and robust nutrition, to create a new generation of delicious, better-for-you and better for the planet meat alternatives," adds Razmovich. "Meala delivers a powerful, high-protein texturizing solution, providing manufacturers with a scalable alternative to less-desirable additives. About Meala FoodTech Meala FoodTech was founded in 2021 by product-innovation specialists Hadar Ekhoiz Razmovich, Tali Feldman Sivan, PhD; and Liran Gruda, CTO. United by a shared vision, the trio set out to revolutionize food production with clean-label, functional ingredients that create better-for-you foods. Meala is backed by leading investors, including The Kitchen Hub, dsm-firmenich Ventures, Lasenor Emul SPA, EIT food, and Milk & Honey Ventures. For more information, contact: Company Contact: Press Contact: Meala FoodTech NutriPR Rom Elias Liat Simha Business Development & Marketing Project Manager Tel: +972-9-9742893 E-mail: Info@ E-mail: liat@ Web: Web: 1 Photo: View original content to download multimedia: SOURCE Meala
Yahoo
an hour ago
- Yahoo
Biodefense Market worth $1.81 billion by 2030 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ -- The biodefense market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period according to a new report by MarketsandMarkets™. The biodefense market is driven by increasing bioterrorism, growing geopolitical tensions, biological warfare risks, and advancements in technology. Biodefense encompasses a range of tools and systems designed to detect, prevent, and respond to biological threats, including infectious diseases, bioterrorism, and accidental pathogen releases. These include biosensors, rapid detection platforms, decontamination systems, mobile containment units, and AI-driven surveillance tools. The market for biodefense technology is experiencing strong growth due to increasing global concerns over pandemics, biological warfare, and emerging infectious diseases. Download PDF Brochure: Browse in-depth TOC on "Biodefense Market" 196 – Tables56 – Figures217 – Pages Biodefense Market Report Scope: Report Coverage Details Market Revenue in 2025 $ 0.89 billion Estimated Value by 2030 $ 1.81 billion Growth Rate Poised to grow at a CAGR of 15.1% Market Size Available for 2020–2030 Forecast Period 2025–2030 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Technology, Product, Application and Region Geographies Covered North America, Europe, Asia Pacific, and Rest of World Key Market Challenge Infrastructure constraints in low-resource areas Key Market Opportunities Emergence of AI-powered biosurveillance and predictive analytics Key Market Drivers Rising threat of Bioterrorism Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Hospitals are the initial point of contact for the identification of unusual infections or exposure to biological agents, and hence, they must have sophisticated containment systems, sterilization apparatus, and pathogen detection instruments in real time. With increasing bioterrorism, governments and health agencies are investing heavily in the upgrade of hospital biosafety facilities, such as Class III biological safety cabinets, mobile isolation units, and UV sterilization technology, all of which are becoming essential for modern biodefense infrastructure. These facilities need safe conditions to work with high-risk pathogens, which fuels the demand for low-temperature sterilizers, decontamination chambers, and air purification. The growing incorporation of digital surveillance platforms and smart biodefense technologies in healthcare facilities further solidifies their role in early detection and quick response, making hospitals & medical institutes the largest application segment of the biodefense market. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period due to its significant contributions toward monitoring real-time pathogens, forecasting, and fast decision-making. AI facilitates the convergence and synthesis of large-scale environmental data and enables early threat detection and quick response coordination. Governments and health organizations globally are increasingly using AI platforms to track bio-threats across borders and to automatically report disease transmission for strategic purposes. Additionally, AI technologies are being integrated into biosensor networks, autonomous disinfecting robots, and predictive modeling applications utilized in hospitals, airports, and military bases. The increasing focus on digitally empowered biodefense infrastructure, coupled with significant investments by public and private sectors, is expected to fuel the growth of the AI segment in the global market. Inquiry Before Buying: Asia Pacific is projected to register the highest CAGR during the forecast period. Asia Pacific is projected to register the highest CAGR in the biodefense industry through the forecast period due to increasing investments in public health infrastructure, infectious disease surveillance, and military biosafety capacities. China, India, Japan, and Australia are comprehensively developing their biodefense capabilities. These countries are investing in mobile biosafety laboratories, near-real-time pathogen detection systems, and next-generation decontamination technologies to anticipate future biological threats. Also, the region is experiencing growth in biotechnology R&D, cross-border health security efforts, and government-backed biodefense programs. The growth of local biotech and med-tech firms is also propelling innovation in AI-powered disease monitoring, biosensors, and portable sterilizers for civilian and military applications. The growing population, susceptibility to zoonotic disease, and proactive policy changes are driving significant growth in the regional biodefense market. STERIS (US), ASP International GmbH (a subsidiary of Fortive) (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK) are the major key players in the biodefense companies. These companies have strong distribution networks across regions like North America, Europe, Asia Pacific, and the Rest of the World. Get 10% Free Customization on this Report: Browse Adjacent Market: Aerospace and Defence Market Research Reports & Consulting Related Reports: Border Security Market by Domain (Land, Maritime, Airborne), Vertical (Military, Homeland Security), System (Surveillance Systems, Detection Systems, Communication Systems, Command and Control Systems), Installation & Region – Global Forecast to 2029 CBRN Defense Market by Type (Chemical, Biological, Radiological, Nuclear, Explosives), Equipment (Protective Wearables, Respiratory Systems, Detection & Monitoring Systems, Decontamination Systems, Simulators, Others), End Use and Region - Global Forecast to 2028 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Web Site: Insight: Source: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Hisense Tops Global Rankings in Q1 2025 for MiniLED, 100-inch and over, and Laser TVs
QINGDAO, China, June 6, 2025 /CNW/ -- Hisense, a leading brand in global consumer electronics and home appliances, continues to reinforce its leadership in premium display technology. According to Omdia's Q1 2025 data, Hisense ranked No.1 worldwide by volume share in 100-inch and over TVs, MiniLED TVs, and Laser TVs. Hisense led the 100-inch and over TV market with a 56.7% global volume share, ranking No. 1 in 2023, 2024, and Q1 2025. In MiniLED TVs, Hisense rose to the top with a 29.3% global volume share, reflecting rapid growth and consumer trust in its backlight innovations. Hisense also retained its lead in the Laser TV market, with a commanding 69.6% global volume share, continuing its global dominance after ranking No.1 for consecutive six years, based on Omdia data. This strong performance reflects Hisense's long-term commitment to large-screen innovation, AI-powered imaging, and immersive audio-visual experiences. Hisense was the first brand globally announced as an official partner of the FIFA Club World Cup 2025™, demonstrating its forward-looking strategy and growing international influence. Building on this milestone, Hisense launched its global campaign "Own the Moment", cementing its global leadership and connecting cutting-edge technology with the passion of sports fans worldwide. The campaign reflects Hisense's commitment to empowering unforgettable sports moments with premium technology — allowing fans to see, feel, and own the excitement like never before. Hisense has also partnered with French audio expert Devialet to enhance sound performance across its latest products, delivering a richer and more immersive home entertainment experience. These audio enhancements will be available via software update, with availability depending on specific models and regions. With a commitment to technological excellence and user value, Hisense is well-positioned to maintain its momentum in 2025 and beyond. About Hisense Hisense, founded in 1969, is a globally recognized leader in home appliances and consumer electronics with operations in over 160 countries, specializing in delivering high-quality multimedia products, home appliances, and intelligent IT solutions. According to Omdia, Hisense ranks No. 2 worldwide in total TV shipments (2022-2024) and No. 1 globally in the 100-inch and over TV segment (2023-2025Q1). As the first official partner of the FIFA Club World Cup 2025™, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide. View original content to download multimedia: SOURCE Hisense View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
